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Background:
Duplication of the 8q24.21 chromosomal region has
been associated with 25-­30% of multiple human
cancers across nearly all tumor types (Tseng et. al.,
2014). Specifically, the myelocytomatosis (MYC)
oncogene is located on 8q24.21 and promotes cell
division when overexpressed. It lays adjacent to and
transcribes the non-­coding RNA gene PVT1.
Previous studies discovered that the excision of
PVT1 reduces tumorigenicity, suggesting the
existence of a second oncogene within the region.
Additionally, PVT1 exon 1 and exon 2 encode
proteins PEP-­L and PEP-­C respectively. PEP-­C is
produced by a circular exon 2 through back-­splicing
and has an open reading frame ~50,000 times more
abundance than linear PVT1 RNA.
Purpose:
To determine the importance of Pep-­C by creating a frameshift mutation that destroys PEP-­C but not PEP-­L. CRISPR-­Cas9 will be utilized to derive the null
allele in PEP-­C by cleaving a few base pairs from the exon and repairing the chromosome through Non-­Homologous End Joining (NHEJ).
Experimental Design:
1. Design a 125-­nucleotide “ultramer” containing 1) sequence to
PCR amply the human U6 promoter and 2) PEP-­C (PVT exon
2) target sequence for cleavage by CRISPR/Cas9. In addition:




2. PCR amplify the human U6 promoter using an Ultramer PCR
primer and regular PCR primer. Amplified with Herculase
polymerase instead of Taq.
3. Purified PCR product with “Quiaquick” kit
4. Lipofect the PCR product with a plasmid expressing Cas9
protein into HCT116 cells
5. Grew transfected cells at a low concentration to form colonies.
Then used cloning cylinders to obtain isolate clonal cells. For
each colony, some of the cells were frozen while the rest were
made into DNA.
6. PCR amplifed 48 clonal cell lines.






















PCR amplification and gel electrophoresis failed to show
differences between the cell lines and the HCT control. In
consulting other researchers working with
CRISPR/Cas9, we discovered that minor losses in bases
(1-­3 base losses) would not be detected through agarose
electrophoresis.
Results  from  an  additional  surveyor  technique  conducted  
failed  to  identify  differences  between  the  cell  lines.  
Future  Direction:
Currently, the Marahrens lab has decided to continue the
experiment by lipofecting the HCT116 cells with two
CRISPR/Cas9 targeting constructs instead of one – as
conducted in this experiment. The following two







CTAGCTCTAAAACTCCGGCGCTCAGCTGGGCTTCGGTGTTTCGTCCTTTCCACAAG%PVT1  Exon  2  Sequence:
Purple  is  translated  in  PEP-­C  and  PEP-­L.  Green  is  translated  in  PEP-­








Break is repaired by Non-
Homologous End Joining (NHEJ)
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